BG
QCOR

Bahl & Gaynor’s QUESTCOR PHARMA INC QCOR Stock Holding History

Bahl & Gaynor’s Portfolio QCOR Stock Details QCOR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q4 		– Sell
-8,610
Closed -$499K – 388
2013
Q3 		$499K Sell
8,610
-7,690
-47% -$457K 0.01% 244
2013
Q2 		$741K Buy
+16,300
New +$578K 0.01% 209

Other funds holding QCOR

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
BC
Broadwood Capital New York $1.42B AUM 34.72% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return
TCIM
TIAA CREF Investment Management New York $141B AUM 14.18% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

Bahl & Gaynor's QCOR Position: Q4 2013 in Review

Bahl & Gaynor sold out of QUESTCOR PHARMA INC (QCOR) in Q4 2013, closing a stake of 8,610 shares — an estimated $499K sold.

Bahl & Gaynor first reported a position in QCOR in Q2 2013 and held it in 2 quarters. The position peaked at $741K in Q2 2013. 285 funds tracked by Wall St. Rank hold QCOR as of Q4 2013.

  • Bahl & Gaynor reported no remaining QUESTCOR PHARMA INC position as of Q4 2013 after selling out during the quarter.
  • Bahl & Gaynor sold 8,610 QUESTCOR PHARMA INC shares in Q4 2013, an estimated $499K.
  • Bahl & Gaynor first reported a position in QUESTCOR PHARMA INC in Q2 2013 and held it in 2 quarters.
  • Bahl & Gaynor's QUESTCOR PHARMA INC position peaked at $741K in Q2 2013.
  • 285 funds tracked by Wall St. Rank held QUESTCOR PHARMA INC as of Q4 2013.

Based on Bahl & Gaynor's 13F filing for Q4 2013, filed 14 Feb 2014.